Pharmacogenomics Flashcards
ADME
Absorption, distribution, metabolism, excretion
Pharmacokinetic elements that determine how drug works
Transporters
Transport drug into or out of the body or cells
Phase I
Chemical modification of drug
Part of metabolism
Enables excretion
Phase II
Conjugation reactions of drug
Part of metabolism
Enables excretion
5 ways that polymorphisms affect drugs
- Increasing/decreasing drug transport in and out of cells
- Increasing/decreasing metabolism
- Changes in binding to cellular target
- Increasing/decreasing risk of toxicity or side effects
- Increasing/decreasing efficacy
CYP2D6 and codeine/morphine metabolism
Converts codeine (prodrug with no analgesic activity) into morphine (metabolite with analgesic activity) 5-10% of Caucasians have deletion that causes decreased metabolism ( conversion is reduced, resulting in no pain relief) Duplication causes increased metabolism (conversion is increased, resulting in adverse effects)
UGT2B7 and codeine/morphine metabolism
Converts morphine into morphine-6-glucuronide (active metabolite)
Those homozygous for UGT2B7*2 allele have higher M6G to morphine ratios
Leads to increased codeine effects
Warfarin
Anticoagulant
Inhibits vitamin K cycle (vitamin K epoxide reductase complex subunit 1: converts precursor forms of clotting factors into active forms)
Narrow therapeutic index
Small change in systemic concentration of drug may lead to significant changes in pharmacodynamic response
CYP2C9 and warfarin
Variants of CYP2C9 (metabolizes warfarin) cause reduced coagulation
These patients need less warfarin than average
Polymorphism of VKORC1 and warfarin
A allele of VKORC1 causes reduced coagulation
AA patients need less warfarin than average
G allele of VKORC1 causes increased coagulation
GG patients need more warfarin than average